1 Min Read
Dec 7 (Reuters) - Roche Holding Ag
* Says avastin (bevacizumab) plus chemotherapy receives fda approval for platinum-sensitive recurrent ovarian cancer Further company coverage: (Reporting By Zurich newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.